A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
Amgen heeft een aantal websites gemaakt om u beter tot dienst te zijn bij specifieke vragen.
Do you want to link to this External Website and leave Amgen.nl?
YOU ARE NOW LEAVING THIS WEBSITE. Amgen Netherlands takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.
Wilt u deze Externe Website bezoeken en Amgen.nl verlaten?
U verlaat nu de website van Amgen Nederland. Amgen Nederland draagt geen verantwoordelijkheid voor, en oefent geen controle uit, over de organisaties, meningen or juistheid van de informatie van deze server of website.
Amgen processes personal information about you for different purposes depending on the type of interaction we have with you and using different legitimate grounds provided in the privacy regulation such as: legitimate interest, consent, manage and comply with a contract, legal and regulatory obligations.
Safety reporting of adverse events: Dutch Medicines Act (Geneesmiddelenwet).
Clinical Trials: Law of 24 November 2005, and when applicable Regulation 536/2014, and any nationally implemented legal texts.
Transparency: Code of Conduct for Medicines Advertising of the Dutch Medicines Advertising Foundation (Code Geneesmiddelenreclame, CGR).
Depending on the purposes for which personal information is collected, Amgen may process:
Depending on the purposes for which personal information is collected, such information may be accessed by:
Amgen is a multi-national company headquartered in the United States. Amgen maintains data centers around the world, including in the European Union and the United States. Amgen may process personal information in global databases that can be accessed by authorized Amgen personnel worldwide.
Transfers outside of Europe are made in accordance with applicable privacy laws. Regardless of where your personal information is collected or processed, Amgen maintains and shall ensure that service providers maintain appropriate administrative, technical and physical safeguards to protect information about you.
Transfers of personal information among Amgen and its group entities follow applicable laws and our Binding Corporate Rules (BCRs). For more information on the BCRs, including your ability to file a complaint about any processing of your personal information in violation of the BCRs, please visit http://www.amgen.com/bcr.
For more information on how Amgen uses Model Contracts, please contact Amgen's Privacy Office at: privacyoffice@amgen.com If you want to know more about Model Contracts, including the content of model contracts, go to: http://ec.europa.eu/justice/data-protection/international-transfers/transfer/index_en.htm
Amgen process your personal data for the period necessary to fulfill the purposes outlined in this privacy notice and to preserve your personal information in accordance with the provisions of relevant laws and regulations.
The criteria followed is determined by:
If you wish to receive more information on a specific processing, please contact the Data Protection Officer at Amgen B.V., Minervum 7061, 4817 ZK Breda, Nederland or privacyoffice@amgen.com
According to the right to data portability you can receive your personal data that you provide to Amgen in a structured, commonly used and machine-readable format.
Notice that this right applies subject to certain conditions and can be requested by contacting Amgen’s Privacy Office at privacyoffice@amgen.com
http://ec.europa.eu/newsroom/article29/item-detail.cfm?item_id=612080
Updated April 2018